
Tenecteplase FDA approval in 2025 for Acute Ischaemic Stroke: Pharmacology & Molecular Advantages
Dalia Alghamdi, Albtool Aljassim, Zainab Almubarak, Daniyah Almnsour, Ghadeer Alruways, Aslam Pathan
………………………………p.01-07

‘NeuroPharmac Journal’ is an open-access official peer-reviewed Journal of ‘Author Gate Publications’ publishing three Issues per year (January-April; May-August; September-December).
The ‘NeuroPharmac Journal’ publishes articles from medical research and the health sciences area. The ‘NeuroPharmac Journal’ respects and follows the guidelines of the Committee on Publication Ethics (COPE) and ICMJE's Principles of Transparency and Best Practice for Scholarly Publications.